Different Appearances of Esophageal Squamous Cell Carcinoma in 18F-PSMA PET/CT Versus 18F-FDG PET/CT
An 81-year-old man with a history of prostate cancer, status post radiation therapy, was referred for a prostate-specific membrane antigen (PSMA) PET/CT scan. Fluorine-18 DCF-Pyl (Pylarify) PSMA PET/CT showed focal increased radiotracer uptake at the right prostate and bilateral iliac chain metastatic lymph nodes. The same PSMA PET/CT showed focal increased radiotracer uptake at the junction of the mid to lower esophagus. 18 F-FDG PET/CT identified a large hypermetabolic esophageal mass in the mid to lower esophagus, showing a greater extent of esophageal disease than the PSMA PET/CT. An endoscopic biopsy confirmed poorly differentiated esophageal squamous cell carcinoma.
Authors
- Jian Yu (ORCID: https://orcid.org/0000-0002-1746-8123)
- Jiaqiong Wang (ORCID: https://orcid.org/0000-0002-7738-4001)
- Yi Li (ORCID: https://orcid.org/0009-0001-3681-2305)
- Mohan Doss (ORCID: https://orcid.org/0000-0002-0464-5047)
Institutions
- Fox Chase Cancer Center (US)
- Temple University Health System (US)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-06-06
- DOI
- https://doi.org/10.1097/rlu.0000000000005722
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04